News
Important Only
Iocaste Ventures And Tenx Protocols Enter Into Definitive Agreement
Aug 18 (Reuters) - Iocaste Ventures Inc ICYp.V:IOCASTE VENTURES AND TENX PROTOCOLS ENTER INTO DEFINITIVE AGREEMENTIOCASTE VENTURES INC - TENX PROTOCOLS SHAREHOLDERS TO REVERSE TAKEOVER IOCASTEIOCASTE VENTURES INC - TENX PRIVATE PLACEMENT OFFERING UP TO C$20 MILLIONFurther company coverage: [ICYp.V]Reuters
Mon, Aug 18
Plus Therapeutics Presents Positive Respect-LM Trial Results Of Reyobiq In Leptomeningeal Metastases
Aug 18 (Reuters) - Plus Therapeutics Inc PSTV.O:PLUS THERAPEUTICS PRESENTS POSITIVE RESPECT-LM CLINICAL TRIAL RESULTS OF REYOBIQ™ IN LEPTOMENINGEAL METASTASESPLUS THERAPEUTICS INC - NO DOSE LIMITING TOXICITIES OBSERVED IN TRIALPLUS THERAPEUTICS INC - REYOBIQ SHOWS CLINICAL BENEFIT RATE OVER 75%Reuters
Mon, Aug 18
Aptose Reports Tuspetinib Improves Standard Of Care Treatment Across Diverse Populations Of Diagnosed AML In Trial
Aug 18 (Reuters) - Aptose Biosciences Inc APS.TO:APTOSE REPORTS EARLY DATA DEMONSTRATING TUSPETINIB IMPROVES STANDARD OF CARE TREATMENT ACROSS DIVERSE POPULATIONS OF NEWLY DIAGNOSED AML IN PHASE 1/2 TUSCANY TRIALAPTOSE BIOSCIENCES INC - TUS ADDED TO VEN+AZA SHOWS 100% CR/CRH AT 80 MG AND 120 MGAPTOS...Reuters
Mon, Aug 18
Federal reductions may strain US healthcare workforce, boost workers’ comp, EPL exposure, Marsh’s Norris warns
By Mia MacGregorAug 15 - (The Insurer) - New regulatory developments introduced through President Trump's Big Beautiful Bill could worsen staffing shortages in U.S. healthcare and drive up workers’ compensation and employment practices liability claims, said Gigi Norris, commercial global indust...Reuters
Mon, Aug 18
Ukraine's Zelenskiy: Trump has strength to force Russia into peace
Aug 18 (Reuters) - President Volodymyr Zelenskiy reiterated that Ukraine is ready to work productively to reach peace, in comments after meeting the U.S. special envoy on Ukraine, Keith Kellogg, in Washington."Russia can only be forced into peace through strength, and President Trump has that st...Reuters
Mon, Aug 18
Former New Hampshire governor to head US airline industry lobbying group
WASHINGTON, Aug 18 (Reuters) - Former New Hampshire Governor Chris Sununu, who passed up a chance to run for the U.S. Senate in 2026, will serve as the head of the trade group Airlines for America, the group said Monday. The influential airline lobbying group includes American Airlines AAL.O, De...Reuters
Mon, Aug 18
BlackRock's GIP to take stake in Eni's carbon capture business
MILAN, Aug 18 (Reuters) - U.S. asset manager BlackRock's BLK.N infrastructure fund GIP has agreed to buy a 49.99% stake in Eni's ENI.MI carbon capture and storage business (CCUS), the Italian company said on Monday without disclosing the price.The proposed deal is part of Eni's broader s...Reuters
Mon, Aug 18
Putin briefs India's Modi on Trump summit in phone call, Kremlin says
MOSCOW, Aug 18 (Reuters) - Russian President Vladimir Putin spoke by phone with Indian Prime Minister Narendra Modi on Monday and briefed him on the outcomes of last week's summit in Alaska with U.S. President Donald Trump, the Kremlin said."The leaders discussed the prospects for a long-ter...Reuters
Mon, Aug 18
In A Major Win For Vanda, A Federal Appeals Court Overturns FDA's Order Denying Approval Of Hetlioz For The Treatment Of Jet Lag Disorder
Aug 18 (Reuters) - Vanda Pharmaceuticals Inc VNDA.O:IN A MAJOR WIN FOR VANDA, A FEDERAL APPEALS COURT OVERTURNS FDA'S ORDER DENYING APPROVAL OF HETLIOZ FOR THE TREATMENT OF JET LAG DISORDERReuters
Mon, Aug 18
BioXcel Therapeutics Announces Positive FDA Pre-SNDA Meeting Comments For SNDA Submission For Bxcl501 In Agitation Associated With Bipolar Disorders Or Schizophrenia
Aug 18 (Reuters) - BioXcel Therapeutics Inc BTAI.O:BIOXCEL THERAPEUTICS ANNOUNCES POSITIVE FDA PRE-SNDA MEETING COMMENTS FOR SNDA SUBMISSION FOR BXCL501 IN AGITATION ASSOCIATED WITH BIPOLAR DISORDERS OR SCHIZOPHRENIAReuters
Mon, Aug 18
Traws Pharma Receives Approval To Proceed With Phase 2 Covid Studies With Ratutrelvir, Expects Results By Year-End 2025
Traws Pharma Inc TRAW.O:TRAWS PHARMA RECEIVES APPROVAL TO PROCEED WITH PHASE 2 COVID STUDIES WITH RATUTRELVIR, EXPECTS RESULTS BY YEAR-END 2025TRAWS PHARMA INC - TOP-LINE DATA FROM BOTH TRIALS EXPECTED BY YEAR-END 2025Reuters
Mon, Aug 18
The Cannabist Company Announces Closing On Sale Of Affiliate Repositioning To A Wholesale Strategy In Pennsylvania
Aug 18 (Reuters) - Cannabist Company Holdings Inc CBST.NLB:THE CANNABIST COMPANY ANNOUNCES CLOSING ON SALE OF AFFILIATE; REPOSITIONING TO A WHOLESALE STRATEGY IN PENNSYLVANIAReuters
Mon, Aug 18
Trident Announces Strategic Investment In Web 3.0 E-Commerce Firm Tongxin Innovation Limited
Aug 18 (Reuters) - Trident Digital Tech Holdings Ltd TDTH.O:TRIDENT ANNOUNCES STRATEGIC INVESTMENT IN WEB 3.0 E-COMMERCE FIRM TONGXIN INNOVATION LIMITEDTRIDENT DIGITAL TECH HOLDINGS LTD - TO BUY 30% STAKE IN TONGXINReuters
Mon, Aug 18
